Latest news
21-07-2022 - New JDRF Call: Development of Islet-Targeted Drug Delivery Strategies in Type-1 Diabetes
Funding of up to $900,000 over three years is available for the creation and validation of reagents that convey islet cell type specificity for the purposes of targeted drug delivery for type-1 diabetes.
The Juvenile Diabetes Research Foundation (JDRF) has issued a new Request for Applications, 'Development of Islet-Targeted Drug Delivery Strategies in T1D', to fund the creation and validation of reagents that convey islet cell type specificity for the purposes of targeted drug delivery for the treatment of type-1 diabetes (T1D).
[...]